Placebo adherence and mortality in the heart and estrogen/progestin replacement study

American Journal of Medicine

Volumn 125, Issue 8, 2012, Pages 804-810

  Padula, Amy M ^a,b   Pressman, Alice R ^c   Vittinghoff, Eric ^d   Grady, Deborah ^d,e   Neuhaus, John ^d   Ackerson, Lynn ^c   Rudd, Peter ^b   Avins, Andrew L ^c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adherence; Double blind clinical trials; Placebo

Indexed keywords

ESTROGEN; GESTAGEN; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION;

AGED; CAUSE OF DEATH; CORONARY DISEASE; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASMS; PLACEBO EFFECT; PROPORTIONAL HAZARDS MODELS; RISK; UNITED STATES;

EID: 84864225326     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.02.014     Document Type: Article

References (14)

1. J. Irvine, B. Baker, J. Smith Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Psychosom Med 61 1999 566 575 (Pubitemid 29360322)
2. S.H. Simpson, D.T. Eurich, S.R. Majumdar A meta-analysis of the association between adherence to drug therapy and mortality BMJ 333 2006 15
3. E.J. Gallagher, C.M. Viscoli, R.I. Horwitz The relationship of treatment adherence to the risk of death after myocardial infarction in women JAMA 270 1993 742 744 (Pubitemid 23226634)
4. R.I. Horwitz, C.M. Viscoli, L. Berkman Treatment adherence and risk of death after a myocardial infarction Lancet 336 1990 542 545 (Pubitemid 20278106)
5. A.S. Walker, D. Ford, V. Mulenga Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children AIDS Behav 13 2009 33 41
6. Coronary Drug Project Research Group Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project N Engl J Med 303 1980 1038 1041
7. B.B. Granger, K. Swedberg, I. Ekman Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial Lancet 366 2005 2005 2011 (Pubitemid 41773375)
8. A.L. Avins, A. Pressman, L. Ackerson, P. Rudd, J. Neuhaus, E. Vittinghoff Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction J Gen Intern Med 25 2010 1275 1281
9. A. Pressman, A.L. Avins, J. Neuhaus, L. Ackerson, P. Rudd Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST) Contemp Clin Trials 33 2012 492 498
10. D. Grady, W. Applegate, T. Bush, C. Furberg, B. Riggs, S.B. Hulley Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics Control Clin Trials 19 1998 314 335 (Pubitemid 28355757)
11. S. Hulley, D. Grady, T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613 (Pubitemid 28502636)
12. D.G. Kleinbaum, M. Klein Survival Analysis 2nd ed. 2005 Springer New York
13. A.L. Avins, A. Pressman, L. Ackerson, P. Rudd, J. Neuhaus, E. Vittinghoff Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction J Gen Intern Med 25 2010 1275 1281
14. S.M. Cazajkowski, M.A. Chesney, A.W. Smith Adherence and Placebo Effect 1990 Springer Publishing Company, Inc New York